Akkulak, M. Et Al. 2024. Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.. Anti-cancer agents in medicinal chemistry , vol.24 , 372-378.

Akkulak, M., Evin, E., Durukan, O., Celebioglu, H. U., & Adali, O., (2024). Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.. Anti-cancer agents in medicinal chemistry , vol.24, 372-378.

Akkulak, MERVE Et Al. "Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.," Anti-cancer agents in medicinal chemistry , vol.24, 372-378, 2024

Akkulak, MERVE Et Al. "Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.." Anti-cancer agents in medicinal chemistry , vol.24, pp.372-378, 2024

Akkulak, M. Et Al. (2024) . "Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.." Anti-cancer agents in medicinal chemistry , vol.24, pp.372-378.

@article{article, author={MERVE AKKULAK Et Al. }, title={Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.}, journal={Anti-cancer agents in medicinal chemistry}, year=2024, pages={372-378} }